Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.13 is 52% below its 5-year average of 2.36, near the low end of its 5-year range (0.62–5.07).
As of the fiscal period ended Tuesday, June 30, 2026. 28.57% above its 12-month average of 0.88.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.13.
QUICK RATIO (ACID-TEST)
1.13
QUICK RATIO (ACID-TEST) AVG TTM
0.88
QUICK RATIO (ACID-TEST) AVG 3Y
1.75
QUICK RATIO (ACID-TEST) AVG 5Y
2.36
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.57%
CURRENT VS 3Y AVG
-35.36%
CURRENT VS 5Y AVG
-52.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-66.33%
vs the sector median at left
Market Cap
$83.24M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$82.69M
Quick Ratio (Acid-Test)
8.75
TTM Avg
11.02
3Y Avg
14.04
5Y Avg
18.21
Market Cap
$82.44M
Quick Ratio (Acid-Test)
5.74
TTM Avg
2.67
3Y Avg
4.44
5Y Avg
7.03
Market Cap
$84.03M
Quick Ratio (Acid-Test)
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$84.15M
Quick Ratio (Acid-Test)
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$80.67M
Quick Ratio (Acid-Test)
16.14
TTM Avg
3.54
3Y Avg
1.85
5Y Avg
1.85
Market Cap
$80.90M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$80.53M
Quick Ratio (Acid-Test)
4.02
TTM Avg
5.44
3Y Avg
3.75
5Y Avg
3.66
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENSAR Inc (LNSR) | $83.15M | 1.13 | 0.88 | 1.75 | 2.36 |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | 3.30 | 5.38 | 8.10 | 12.75 |
| MediciNova, Inc. (MNOV)vs › | $82.69M | 8.75 | 11.02 | 14.04 | 18.21 |
| Humacyte, Inc. (HUMA)vs › | $82.44M | 5.74 | 2.67 | 4.44 | 7.03 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.03M | 7.85 | 4.70 | 2.98 | 5.25 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.15M | 7.03 | 3.05 | 3.90 | 4.20 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $80.67M | 16.14 | 3.54 | 1.85 | 1.85 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | 7.99 | 9.12 | 12.06 | 14.25 |
| Nutriband Inc. (NTRB)vs › | $80.53M | 4.02 | 5.44 | 3.75 | 3.66 |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | 0.34 | 0.10 | 0.26 | 0.26 |
Quick Ratio
1.13
Excludes inventory
Current Ratio
2.39
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.13 |
| 2026-03-31 | 1.08 |
| 2025-12-31 | 0.62 |
| 2025-09-30 | 0.67 |
| 2025-06-30 | 0.88 |
| 2025-03-31 | 1.25 |
| 2024-12-31 | 2.04 |
| 2024-09-30 | 2.10 |
| 2024-06-30 | 2.15 |
| 2024-03-31 | 2.36 |
| 2023-12-31 | 2.64 |
| 2023-09-30 | 2.83 |
| 2023-06-30 | 2.94 |
| 2023-03-31 | 1.43 |
| 2022-12-31 | 1.92 |
| 2022-09-30 | 2.48 |
| 2022-06-30 | 2.62 |
| 2022-03-31 | 4.41 |
| 2021-12-31 | 4.40 |
| 2021-09-30 | 4.55 |
| 2021-06-30 | 5.07 |
| 2021-03-31 | 6.79 |
| 2020-12-31 | 5.30 |
| 2020-09-30 | 5.60 |
| 2020-06-30 | 1.32 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.16 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
